No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Friday, October 24, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Trading

Jigsaw daytradr 5008 – Production Release

by TheAdviserMagazine
5 months ago
in Trading
Reading Time: 1 min read
A A
Jigsaw daytradr 5008 – Production Release
Share on FacebookShare on TwitterShare on LInkedIn


We’re excited to announce the release of Jigsaw daytradr 5008 Production Release.

You can download it HERE. The Release Notes are available HERE.

We strongly encourage you to upgrade to this version, as older versions of daytradr will be retired in the future.

A big thank you to everyone for your patience—and especially for taking the time to report bugs during the Beta releases. Your feedback has been invaluable.

We’ve got exciting plans ahead to continue delivering the tools you need. The Trade Copier is currently in development. You can leave your thoughts and suggestions in this RFI thread.

If you’d like to request new features or improvements, feel free to drop your ideas in THIS Discord Channel.

Good Trading!

Gonzalo

 

 



Source link

Tags: daytradrJigsawproductionRelease
ShareTweetShare
Previous Post

How might China win the future? Ask Google’s AI

Next Post

Analysis-Companies turn to private credit during tariff turmoil for loans

Related Posts

edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

by TheAdviserMagazine
October 24, 2025
0

Zilebesiran in Phase 3! Pharma-Aktie Alnylam Pharmaceuticals (ALNY) testet 20er-EMA mit Rücksetzer vom Allzeithoch! JETZT einsteigen? Kursziel nach Measured Move...

edit post
Shell: Energieriese nach monatelanger Seitwärtsphase im Aufwind!

Shell: Energieriese nach monatelanger Seitwärtsphase im Aufwind!

by TheAdviserMagazine
October 23, 2025
0

Bleiben die Öl-Bullen am Ball? Rückblick Die Aktie des Energiekonzerns Shell verzeichnete am Donnerstag, dem 23. Oktober 2025, einen deutlichen...

edit post
Eli Lilly – LLY: Die Pharma-Aktie sendet starke bullische Signale, aber …!

Eli Lilly – LLY: Die Pharma-Aktie sendet starke bullische Signale, aber …!

by TheAdviserMagazine
October 23, 2025
0

Q3-Zahlen in Kürze! Neue Kursrallye bei der Eli-Lilly-Aktie (LLY)? Orforglipron in Phase 3. GLP-1-Medikament als Tablette statt Spritze könnte für...

edit post
Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

by TheAdviserMagazine
October 22, 2025
0

Pullback könnte eine Fortsetzung des Runs bedeuten! Rückblick Der Chart von Usa Rare Earth zeigt eine sehr dynamische Aufwärtsbewegung, die...

edit post
StoneX Group – SNEX: Der Finanzdienstleister hat Bock auf Wurst!

StoneX Group – SNEX: Der Finanzdienstleister hat Bock auf Wurst!

by TheAdviserMagazine
October 22, 2025
0

Earnings am 19.11. nach Börsenschluss! Pullback Setup mit Kursziel Allzeithoch! StoneX (SNEX) übernimmt Right Corp. und stärkt sein globales Fleischhandelsgeschäft!...

edit post
Protagonist Therapeutics – PTGX: Einstieg von Johnson & Johnson könnte für Mega-Bounce sorgen!

Protagonist Therapeutics – PTGX: Einstieg von Johnson & Johnson könnte für Mega-Bounce sorgen!

by TheAdviserMagazine
October 21, 2025
0

Springt die Aktie auf 100 USD? Übernahmegerüchte heizen Kursentwicklung bei Protagonist Therapeutics (PTGX) an: + 67 Prozent in 6 Monaten!...

Next Post
edit post
Analysis-Companies turn to private credit during tariff turmoil for loans

Analysis-Companies turn to private credit during tariff turmoil for loans

edit post
India has a chance to cure its investment malaise

India has a chance to cure its investment malaise

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Links 10/23/2025 | naked capitalism

Links 10/23/2025 | naked capitalism

0
edit post
Ikea CEO Jesper Brodin may get chance to run UN division like a business

Ikea CEO Jesper Brodin may get chance to run UN division like a business

0
edit post
SBI-Owned B2C2 Announces Zero-Fee Stablecoin Swap Platform for Institutions

SBI-Owned B2C2 Announces Zero-Fee Stablecoin Swap Platform for Institutions

0
edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

0
edit post
WEP/GPO Repealed—Now What? 6 Steps for Teachers, Firefighters, and Public Workers to Recheck Benefits in 2025

WEP/GPO Repealed—Now What? 6 Steps for Teachers, Firefighters, and Public Workers to Recheck Benefits in 2025

0
edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

0
edit post
Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!

October 24, 2025
edit post
China strikes conciliatory tone ahead of expected Trump-Xi meeting

China strikes conciliatory tone ahead of expected Trump-Xi meeting

October 24, 2025
edit post
Hyperliquid Price Breaks Key Resistance as B Fundraising and IPO Plans Gain Traction

Hyperliquid Price Breaks Key Resistance as $1B Fundraising and IPO Plans Gain Traction

October 24, 2025
edit post
Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

Tomatoes Rs 600 per kg, capsicum Rs 300: Pakistanis are paying a heavy price after conflict with Afghanistan

October 24, 2025
edit post
Europe Fears A US Civil War – Whiskey Rebellion To Now

Europe Fears A US Civil War – Whiskey Rebellion To Now

October 24, 2025
edit post
US Dollars Go On-Chain as Uphold and Vast Bank Fuse Banking With Blockchain

US Dollars Go On-Chain as Uphold and Vast Bank Fuse Banking With Blockchain

October 23, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Alnylam Pharmaceuticals – ALNY: Volkskrankheit Bluthochdruck im Visier!
  • China strikes conciliatory tone ahead of expected Trump-Xi meeting
  • Hyperliquid Price Breaks Key Resistance as $1B Fundraising and IPO Plans Gain Traction
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.